Thermo Fisher Scientific Inc.
TMO
Market Cap$206.71B
Close$
Earnings Call Q4 2023
January 31, 2024 - AI Summary
Thermo Fisher Scientific reported strong fourth quarter results, with revenue of $10.89 billion and adjusted EPS of $5.67 per share.
The company's full year revenue for 2023 was $42.9 billion, with adjusted EPS of $21.55 per share.
Thermo Fisher demonstrated strong execution in a challenging macroeconomic environment, delivering above-market growth and gaining market share.
Exclusive for Stockcircle Pro members
Sign up
$742.05
28.5% upside
Current Fair Value
28.5% upsideUndervalued by 28.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $206.71 Billion |
|---|---|
| Enterprise Value | $233.55 Billion |
| Dividend Yield | $1.4386 (0.27%) |
| Earnings per Share | $15.45 |
| Beta | 0.98 |
| Outstanding Shares | 381,713,867 |
| Avg 30 Day Volume | 1,263,193 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 34.48 |
|---|---|
| PEG | 1006.3 |
| Price to Sales | 5.16 |
| Price to Book Ratio | 4.73 |
| Enterprise Value to Revenue | 5.45 |
| Enterprise Value to EBIT | 32.17 |
| Enterprise Value to Net Income | 38 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.75 |
Revenue Sources
No data
ESG Score
No data
About Thermo Fisher Scientific Inc.
75,000 employees
CEO: Marc Casper Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...